CLEC7A and tauopathy: Cst7, a lysosomal protease inhibitor, has been shown to modulate microglial inflammatory responses in tauopathy models, while Clec7a (Dectin‐1) mediates amyloid‐beta phagocytosis (Rasmussen et al. 2022).